Transgender Patients With Cancer

JAMA Oncology

EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, NOVEMBER 12, 2020

Media advisory: The full article is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2020.5671?guestAccessKey=45eb7050-70b9-45c7-9b45-0a6849398175&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=111220

 

What The Study Did: This case series examined demographic, clinical and treatment characteristics of transgender patients with cancer and their outcomes

Authors: Daphne A. Haas-Kogan, M.D., and Kevin X. Liu, M.D., D.Phil., of Brigham and Women’s Hospital/Dana-Farber Cancer Institute in Boston, are the corresponding authors.

 

(doi:10.1001/jamaoncol.2020.5671)

Editor’s Note: The article includes conflicts of interest disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.